Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    06-December-2000      
Issue 237 Next Update - 14:00 UTC 08:00 EST    07-December-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 06-December-2000:

The following stories appear in full on today's Vidyya Medical News Service Web site.

Wood dust produced in furniture and cabinet manufacture, and common talc are among the substances being considered for listing in the next federal Report on Carcinogens. To assist the National Toxicology Program in preparing the report, a group of scientific advisers will review the proposed substances Dec. 13-15 at the Wyndham City Center, 1143 New Hampshire Ave. NW, Washington, D.C. The meeting is open to the public.

For more information: Wood Dust, Talc, Estrogens, And Nickel Alloys Among Substances Being Reviewed For Inclusion In Report On Carcinogens

Bayer Diagnostics announced today that the US Food and Drug Administration (FDA) has issued a clearance of its 510(k) application for the Bayer HER-2/neu serum test for use in the follow-up and monitoring of patients with metastatic breast cancer. The Bayer serum HER-2/neu test is the first FDA-cleared blood test for measuring circulating levels of the HER-2/neu oncoprotein.

For more information: New Breast Cancer Monitoring Test Receives FDA Clearance

In the largest prospective study of cigarette smoking and colorectal cancer mortality, American Cancer Society staff researchers report finding strong evidence for classifying cancers of the colon and rectum as, in part, smoking-related.

For more information: Colorectal Cancer Traced To Smoking

An advisory panel to the US Food and Drug Administration (FDA) today took a first step to facilitate use by US cardiologists of emerging therapeutic options to help many Americans suffering from atrial fibrillation, the world's most common heart rhythm disorder. The panel, made up of physicians, other scientists and consumer members, voted to recommend that the FDA approve expansion of indications for the use of the Medtronic Jewel® AF implantable cardioverter defibrillator, which was approved by the agency for US commercial release in June 2000.

For more information: US FDA Panel Recommends New Therapy Option For Select Group Of Atrial Fibrillation Patients

Yesterday, the AMA approved recommendations regarding greater access to emergency contraception pills (ECPs). Two brand names for emergency contraceptive pills are Preven and Plan B. You can get prescribing information for Preven by searching Vidyya with keyword - Preven.

For more information: AMA Statement On Access To Emergency Contraception

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Vidyya Home |  Home Of Our Sponsor, Vidyya. | Vidyya Archives | Search Vidyya  | Visit Our Library | Subscribe To Our News Service | All About Us | Get Vidyya For Your Website
Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.